北美先进药物输送系统市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按类型、应用、技术(前药、植入物和宫内节育器、靶向药物递送、聚合物药物递送、其他技术)和地理划分

市场快照

Picture1North America Advanced Drug Delivery Systems
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 4.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计北美药物输送系统市场在预测期内的复合年增长率约为 4.8%。推动这一市场的因素包括新药和生物制剂的开发、对人类生物学和疾病的了解的进步以及研发支出的增加。

先进的药物输送系统更侧重于根据患者要求维持药物的生物利用度以及药物输送的速度。基因工程导致了新策略的发展,以提供生物技术衍生的蛋白质、肽药物和化学免疫偶联物。先进的药物和生物制剂具有更高的效率,药物剂量更小,因此它们必须得到先进的药物输送系统的支持,才能从药物中获得最大的疗效。除了药物和生物制剂外,药物洗脱植入物还有可能提供不间断的治疗和减少药物剂量(因此不需要频繁给药)。先进的缓释系统有助于针对肠道感染和其他感染。

此外,世界范围内不断增加的疾病负担、控释给药系统在解决多种疾病方面的成熟功效,以及创新者和仿制药企业对先进给药系统的研发趋势不断增长,都在推动增长。的市场。然而,先进药物输送产品的产品召回和基于纳米药物的药物输送面临的挑战等因素成为市场增长的主要制约因素。

报告范围

先进的给药系统的概念是增加药物的疗效。采用先进的给药系统,提高药物的生物利用度,减少不良反应和副作用,增加药物稳定性。

Type
Oral Drug Delivery System
Injection-based Drug Delivery System
Inhalation/Pulmonary Drug Delivery System
Transdermal Drug Delivery System
Trans mucosal Drug Delivery System
Carrier-based Drug Delivery System
Other Types
Application
Cardiovascular Diseases
Oncology
Urology
Diabetes
CNS
Ophthalmology
Inflammatory Diseases
Infections
Other Applications
Technology
Prodrug
Implants and Intrauterine Devices
Targeted Drug Delivery
Polymeric Drug Delivery
Other Technologies
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

主要市场趋势

基于注射的给药系统主导北美先进给药系统市场

技术进步过程导致出现改进和增强的设备,以及针对不同类别的患者护理量身定制的设备。此外,双注射给药系统等技术创新进一步提升了给药方式。它们还提供许多可提高可用性、安全性、功效和合规性的特性和功能,以及许多其他功能,例如连接性甚至诊断。随着自动注射器、笔式注射器和无针注射器等自动注射装置的出现,注射药物输送 (IDD) 的使用变得相对容易,允许患者在家中给药而无需医疗协助。糖尿病患者数量的增加使该市场的大多数领先企业能够在自我注射装置的帮助下推出胰岛素给药装置。因此,家庭护理机构是注射给药系统的最大最终用户。

01

竞争格局

北美先进的药物输送系统市场竞争适度。这个市场的一些主要参与者是 3M、拜耳、辉瑞公司等。由于药物输送系统的技术不断进步,未来市场有可能出现新的进入者。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Development of New Drugs and Biologics

      2. 4.2.2 Advancements in Understanding Human Biology and Diseases

      3. 4.2.3 Increased R&D Spending

    3. 4.3 Market Restraints

      1. 4.3.1 Product Recalls of Advanced Drug Delivery Products

      2. 4.3.2 Challenges in Nanomedicine-based Drug Delivery

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Oral Drug Delivery System

      2. 5.1.2 Injection-based Drug Delivery System

      3. 5.1.3 Inhalation/Pulmonary Drug Delivery System

      4. 5.1.4 Transdermal Drug Delivery System

      5. 5.1.5 Trans mucosal Drug Delivery System

      6. 5.1.6 Carrier-based Drug Delivery System

      7. 5.1.7 Other Types

    2. 5.2 Application

      1. 5.2.1 Cardiovascular Diseases

      2. 5.2.2 Oncology

      3. 5.2.3 Urology

      4. 5.2.4 Diabetes

      5. 5.2.5 CNS

      6. 5.2.6 Ophthalmology

      7. 5.2.7 Inflammatory Diseases

      8. 5.2.8 Infections

      9. 5.2.9 Other Applications

    3. 5.3 Technology

      1. 5.3.1 Prodrug

      2. 5.3.2 Implants and Intrauterine Devices

      3. 5.3.3 Targeted Drug Delivery

      4. 5.3.4 Polymeric Drug Delivery

      5. 5.3.5 Other Technologies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 3M

      2. 6.1.2 Aradigm Corporation

      3. 6.1.3 Amgen Inc

      4. 6.1.4 Astrazeneca PLC

      5. 6.1.5 Bayer Healthcare

      6. 6.1.6 Boston Scientific Corporation

      7. 6.1.7 Pfizer Inc

      8. 6.1.8 Merck & Co, Inc

      9. 6.1.9 Novartis AG

      10. 6.1.10 West Pharmaceutical Services, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Advanced Drug Delivery Systems Market market is studied from 2018 - 2026.

The North America Advanced Drug Delivery Systems Market is growing at a CAGR of 4.8% over the next 5 years.

3M, Aradigm Corporation, Boston Scientific Corporation, West Pharmaceutical Services, Inc., Pfizer Inc. are the major companies operating in North America Advanced Drug Delivery Systems Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!